title: The clinical use of granulocyte-colony stimulating factor.
authors: Core Medical Trainee Cambridge University Health Partners, Addenbrookes Hospital, Cambridge.
authors: Jagruti
authors: J
authors: Shah
authors: Academic Clinical Lecturer in Medical Oncology in the Department of Oncology, Cambridge University Health Partners, Addenbrookes Hospital, Cambridge.
authors: Sarah J
authors: SJ
authors: Welsh
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D064147:Febrile Neutropenia / Q000139:chemically induced* / Q000188:drug therapy / Q000517:prevention & control*; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000078224:Lenograstim; D011092:Polyethylene Glycols; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; C455861:pegfilgrastim; D011092:Polyethylene Glycols; D000078224:Lenograstim; D000069585:Filgrastim